2023-03-012024-02-292024-02-29false08387668CONCIERGE MEDICAL PRACTICE LIMITED2024-09-2486210iso4217:GBPxbrli:pure083876682023-03-01083876682024-02-29083876682023-03-012024-02-29083876682022-03-01083876682023-02-28083876682022-03-012023-02-2808387668bus:SmallEntities2023-03-012024-02-2908387668bus:AuditExempt-NoAccountantsReport2023-03-012024-02-2908387668bus:AbridgedAccounts2023-03-012024-02-2908387668bus:PrivateLimitedCompanyLtd2023-03-012024-02-2908387668core:WithinOneYear2024-02-2908387668core:AfterOneYear2024-02-2908387668core:WithinOneYear2023-02-2808387668core:AfterOneYear2023-02-2808387668core:ShareCapital2024-02-2908387668core:SharePremium2024-02-2908387668core:RevaluationReserve2024-02-2908387668core:OtherReservesSubtotal2024-02-2908387668core:RetainedEarningsAccumulatedLosses2024-02-2908387668core:ShareCapital2023-02-2808387668core:SharePremium2023-02-2808387668core:RevaluationReserve2023-02-2808387668core:OtherReservesSubtotal2023-02-2808387668core:RetainedEarningsAccumulatedLosses2023-02-2808387668core:LandBuildings2024-02-2908387668core:PlantMachinery2024-02-2908387668core:Vehicles2024-02-2908387668core:FurnitureFittings2024-02-2908387668core:OfficeEquipment2024-02-2908387668core:NetGoodwill2024-02-2908387668core:IntangibleAssetsOtherThanGoodwill2024-02-2908387668core:ListedExchangeTraded2024-02-2908387668core:UnlistedNon-exchangeTraded2024-02-2908387668core:LandBuildings2023-02-2808387668core:PlantMachinery2023-02-2808387668core:Vehicles2023-02-2808387668core:FurnitureFittings2023-02-2808387668core:OfficeEquipment2023-02-2808387668core:NetGoodwill2023-02-2808387668core:IntangibleAssetsOtherThanGoodwill2023-02-2808387668core:ListedExchangeTraded2023-02-2808387668core:UnlistedNon-exchangeTraded2023-02-2808387668core:LandBuildings2023-03-012024-02-2908387668core:PlantMachinery2023-03-012024-02-2908387668core:Vehicles2023-03-012024-02-2908387668core:FurnitureFittings2023-03-012024-02-2908387668core:OfficeEquipment2023-03-012024-02-2908387668core:NetGoodwill2023-03-012024-02-2908387668core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2908387668core:ListedExchangeTraded2023-03-012024-02-2908387668core:UnlistedNon-exchangeTraded2023-03-012024-02-2908387668core:MoreThanFiveYears2023-03-012024-02-2908387668core:Non-currentFinancialInstruments2024-02-2908387668core:Non-currentFinancialInstruments2023-02-2808387668dpl:CostSales2023-03-012024-02-2908387668dpl:DistributionCosts2023-03-012024-02-2908387668core:LandBuildings2023-03-012024-02-2908387668core:PlantMachinery2023-03-012024-02-2908387668core:Vehicles2023-03-012024-02-2908387668core:FurnitureFittings2023-03-012024-02-2908387668core:OfficeEquipment2023-03-012024-02-2908387668dpl:AdministrativeExpenses2023-03-012024-02-2908387668core:NetGoodwill2023-03-012024-02-2908387668core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2908387668dpl:GroupUndertakings2023-03-012024-02-2908387668dpl:ParticipatingInterests2023-03-012024-02-2908387668dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2908387668core:ListedExchangeTraded2023-03-012024-02-2908387668dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2908387668core:UnlistedNon-exchangeTraded2023-03-012024-02-2908387668dpl:CostSales2022-03-012023-02-2808387668dpl:DistributionCosts2022-03-012023-02-2808387668core:LandBuildings2022-03-012023-02-2808387668core:PlantMachinery2022-03-012023-02-2808387668core:Vehicles2022-03-012023-02-2808387668core:FurnitureFittings2022-03-012023-02-2808387668core:OfficeEquipment2022-03-012023-02-2808387668dpl:AdministrativeExpenses2022-03-012023-02-2808387668core:NetGoodwill2022-03-012023-02-2808387668core:IntangibleAssetsOtherThanGoodwill2022-03-012023-02-2808387668dpl:GroupUndertakings2022-03-012023-02-2808387668dpl:ParticipatingInterests2022-03-012023-02-2808387668dpl:GroupUndertakingscore:ListedExchangeTraded2022-03-012023-02-2808387668core:ListedExchangeTraded2022-03-012023-02-2808387668dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-03-012023-02-2808387668core:UnlistedNon-exchangeTraded2022-03-012023-02-2808387668core:NetGoodwill2024-02-2908387668core:IntangibleAssetsOtherThanGoodwill2024-02-2908387668core:LandBuildings2024-02-2908387668core:PlantMachinery2024-02-2908387668core:Vehicles2024-02-2908387668core:FurnitureFittings2024-02-2908387668core:OfficeEquipment2024-02-2908387668core:AfterOneYear2024-02-2908387668core:WithinOneYear2024-02-2908387668core:ListedExchangeTraded2024-02-2908387668core:UnlistedNon-exchangeTraded2024-02-2908387668core:ShareCapital2024-02-2908387668core:SharePremium2024-02-2908387668core:RevaluationReserve2024-02-2908387668core:OtherReservesSubtotal2024-02-2908387668core:RetainedEarningsAccumulatedLosses2024-02-2908387668core:NetGoodwill2023-02-2808387668core:IntangibleAssetsOtherThanGoodwill2023-02-2808387668core:LandBuildings2023-02-2808387668core:PlantMachinery2023-02-2808387668core:Vehicles2023-02-2808387668core:FurnitureFittings2023-02-2808387668core:OfficeEquipment2023-02-2808387668core:AfterOneYear2023-02-2808387668core:WithinOneYear2023-02-2808387668core:ListedExchangeTraded2023-02-2808387668core:UnlistedNon-exchangeTraded2023-02-2808387668core:ShareCapital2023-02-2808387668core:SharePremium2023-02-2808387668core:RevaluationReserve2023-02-2808387668core:OtherReservesSubtotal2023-02-2808387668core:RetainedEarningsAccumulatedLosses2023-02-2808387668core:NetGoodwill2022-03-0108387668core:IntangibleAssetsOtherThanGoodwill2022-03-0108387668core:LandBuildings2022-03-0108387668core:PlantMachinery2022-03-0108387668core:Vehicles2022-03-0108387668core:FurnitureFittings2022-03-0108387668core:OfficeEquipment2022-03-0108387668core:AfterOneYear2022-03-0108387668core:WithinOneYear2022-03-0108387668core:ListedExchangeTraded2022-03-0108387668core:UnlistedNon-exchangeTraded2022-03-0108387668core:ShareCapital2022-03-0108387668core:SharePremium2022-03-0108387668core:RevaluationReserve2022-03-0108387668core:OtherReservesSubtotal2022-03-0108387668core:RetainedEarningsAccumulatedLosses2022-03-0108387668core:AfterOneYear2023-03-012024-02-2908387668core:WithinOneYear2023-03-012024-02-2908387668core:Non-currentFinancialInstrumentscore:CostValuation2023-03-012024-02-2908387668core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-012024-02-2908387668core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-012024-02-2908387668core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-012024-02-2908387668core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-012024-02-2908387668core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-012024-02-2908387668core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2908387668core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2908387668core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2908387668core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2908387668core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2808387668core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2808387668core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2808387668core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2808387668core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2808387668core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2808387668core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2808387668core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2808387668core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2808387668bus:Director12023-03-012024-02-2908387668bus:Director22023-03-012024-02-2908387668bus:Director32023-03-012024-02-29

CONCIERGE MEDICAL PRACTICE LIMITED

Registered Number
08387668
(England and Wales)

Unaudited Financial Statements for the Year ended
29 February 2024

CONCIERGE MEDICAL PRACTICE LIMITED
Company Information
for the year from 1 March 2023 to 29 February 2024

Directors

Dr Karl Braine
Mrs Kathleen Carrick
Dr Simon Gillson

Company Secretary

Mrs Kathleen Carrick

Registered Address

Lynley House Moreton Paddox
Moreton Morrell
Warwick
CV35 9BU

Registered Number

08387668 (England and Wales)
CONCIERGE MEDICAL PRACTICE LIMITED
Statement of Financial Position
29 February 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets35,3795,067
5,3795,067
Current assets
Stocks20,00010,250
Debtors103,171121,307
Cash at bank and on hand773,843695,545
897,014827,102
Creditors amounts falling due within one year(223,056)(182,405)
Net current assets (liabilities)673,958644,697
Total assets less current liabilities679,337649,764
Creditors amounts falling due after one year(72,695)(133,874)
Net assets606,642515,890
Capital and reserves
Called up share capital117117
Share premium32,58532,585
Profit and loss account573,940483,188
Shareholders' funds606,642515,890
The financial statements were approved and authorised for issue by the Board of Directors on 24 September 2024, and are signed on its behalf by:
Mrs Kathleen Carrick
Director
Registered Company No. 08387668
CONCIERGE MEDICAL PRACTICE LIMITED
Notes to the Financial Statements
for the year ended 29 February 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Plant and machinery25
Fixtures and fittings25
Office Equipment25
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20242023
Average number of employees during the year3030
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 March 239,663
Additions2,035
At 29 February 2411,698
Depreciation and impairment
At 01 March 234,595
Charge for year1,724
At 29 February 246,319
Net book value
At 29 February 245,379
At 28 February 235,067